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1 |  INTRODUCTION
Williams syndrome (WBS, OMIM number #194050), 
with an estimated prevalence ranging from 1:7,500 to 
1:20,000, is a genetic multi‐system disorder. It is caused 
by hemizygosity at chromosomal site 7q11.23 (Brewer & 
Morrison &Tolmie, 1996; Pober, 2010). Various somatic 
comorbidities and symptoms include characteristic facial 
features and body structure, cardiovascular disease (su-
pravalvar aortic stenosis, hypertension), connective tissue 
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Abstract
Background: Williams syndrome (WBS) is a genetic multisystem disorder. The 
main symptom is borderline (intelligence quotient, IQ 70–79) or abnormally low in-
telligence (IQ < 70). According to earlier studies young individuals with WBS dem-
onstrate generally a slightly higher verbal IQ (VIQ) compared to performance/
nonverbal IQ (PIQ). WBS was recognized as a distinct entity already about 60 years 
ago, but still cognition in adults with WBS is poorly known.
Methods: We followed 25 adults (age at baseline 19–68, median 38) with geneti-
cally confirmed WBS for about 20 years. The study subjects underwent medical and 
neuropsychological assessments at the baseline and at the end of follow‐up.
Results: The mean VIQ remained quite stable from early adulthood up to 40 years of 
age after which it declined. The mean PIQ kept on improving from early adulthood 
until 50 years of age after which it gradually declined. At the end of the study, all 
study subjects had at least two longstanding health problems out of which hyperten-
sion, psychiatric disorder, and scoliosis or kyphosis occurred most frequently. At end 
of the study, two patients suffered from vascular dementia. Seven patients died dur-
ing the follow‐up.
Conclusions: In adults with WBS, the course of cognition is uneven across the cog-
nitive profile. Their verbal functions both develop and deteriorate earlier than perfor-
mance/nonverbal functions. Frequent somatic co‐morbidities may increase risk to 
shortened life span.
K E Y W O R D S
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abnormalities and endocrine abnormalities (hypercalcemia, 
hypercalciuria, hypothyroidism, and early puberty) (Morris, 
Demsey, Leonard, Dilts, & Blackburn, 1988; Pober, 2010). 
The main neuropsychiatric symptom is intellectual disability 
(ID), which can range from severe to mild. The behavioral 
phenotype includes pronounced weaknesses in visuospatial 
construction and relative strengths in auditory short‐term 
memory face processing and expressive language, especially 
vocabulary (Martens, Wilson, & Reutens, 2008). Many age 
related medical conditions in WBS appear much earlier than 
expected, in late adolescence or young adulthood. These in-
clude premature graying of the hair, diverticulosis, diabe-
tes mellitus, hypertension, and sensorineural hearing loss. 
With advancing age, adults are also prone to joint contrac-
tures and hyperreflexia, and they often become even more 
unsteady with such motoric tasks as stepping up or down 
stairs (Pober, 2010). Standardized testing in young adults 
demonstrates that their mean verbal intelligence quotient 
(VIQ) is slightly higher than their mean performance intel-
ligence quotient (PIQ) and full‐scale intelligence quotient 
(FSIQ) (Boaddaert et al., ; Howlin, Davies, & Udwin, 1998; 
Martens et al., 2008; Mervis, Kistler, John, & Morris, 2012; 
Searcy et al., 2004) and some earlier studies suggest that 
FSIQ remains stable over an individual's lifetime (Ficher, 
Lense, & Dykens, 2016; Howlin et al., 1998; Howlin, 
Elison, & Udwin, 2010; Martens et al., 2008; Searcy et al., 
2004). Although WBS was already recognized as a distinct 
entity about 60 years ago, the cognition in adults carrying 
this genetic defect continues to be poorly known (Ficher 
et al., 2016; Howlin et al., 2010; Searcy et al., 2004). Our 
study attempted to fill this gap in knowledge by elucidating 
prospectively the cognitive functions and the state of health 
in adults with WBS during a 20‐year clinical follow‐up.
2 |  SUBJECTS AND METHODS
Finland is divided into 16 state‐supported regional service 
districts for individuals with an ID. Initially, all 34 identi-
fied adults from South Häme, Pirkanmaa, and Northern 
Ostrobothnia districts with clinically and genetically con-
firmed WBS were invited to participate in the study. The au-
thors, that is, neuropsychologist, clinical psychologist, and 
neurologists assessed the study subjects at baseline and at end 
of the follow‐up.
The psychologist (OS and VK) chose the most suitable 
testing method for each patient based on a case‐by‐case 
consideration and used the same individually chosen test 
throughout the follow‐up. The cognitive test battery in-
cluded three Wechsler tests: (WAIS‐R, [Wechsler, 1992], 
WISC‐R, [Wechsler, 1984], and WPPSI‐R, [Wechsler, 
1995]); Leiter International Performance Test (LIPS, 
[Leiter, 1980]) and Bayley Scales of Infant Development, 
T A B L E  1  The state of health of the 25 study subjects with WBS 
at the baseline and at end of the follow‐up
 
Baseline  
N (%) End N (%)
Cardiovascular co‐morbidity
Heart defect 4 (16) 10 (40)
Hypertension 5 (17) 17 (68)
Hypercholesterolemiaa ? 9 (36)
Neurological co‐morbidity
Epilepsy 1 (3) 3 (12)
Vascular dementia 0 2 (8)
Transient ischemic attacks 0 5 (20)
Migraine 0 3 (12)
Sleep apneab 0 2 (8)
Dystonic movement disorder 2 (8) 6 (24)
Gastrointestinal co‐morbidity
Diverticulitis 1 (3) 8 (32)
Coeliciac 0 2 (8)
Gastrointestinal reflux 0 6 (24)
Constipation 4 (16) 5 (20)
Rectal prolapse 2 (8) 7 (28)
Psychiatric disorder   
Bipolar mood disorder 2 (8) 2 (8)
Anxiety disorder 3 (12) 3 (12)
Unspecified psychiatric disorder 7 (28) 11 (44)
Autoimmune co‐morbidity
Hypothyroidism 1 (3) 6 (24)
Diabetes type 2 2 (7) 7 (28)
Rheumatoid arthritis 1 (3) 2 (8)
Sensory impairment   
Auditory defect 2 (8) 7 (28)
Visual impairment 3 (12) 8 (32)
Skeletal impairment
Teeth, missing 2 (8) 8 (32)
Scoliosis/kyphosis 8 (32) 11 (44)
Joint luxations 2 (8) 2 (8)
Craniosynostosis‐cleft palate 1 (3) 1 (4)
Other
Cancer 1 (3) 2 (8)
Asthma 0 1 (4)
Chronic urinary infections 1 (3) 2 (8)
Nephrotic insufficiency 1 (3) 1 (4)
Lymphoedema in legs 1 (3) 3 (12)
Hernia 3 (12) 6 (24)
Obesity 10 (40) 7 (28)
ablood cholesterol levels were not routinely measured in 1990s. bsleep 
recordings were not done in 1990s. ccoelicia was not screened in 1990s as often 
as in 2010s. 
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(BSID‐II, [Bayley, 2008]). Wechsler tests are comprised of 
10–12 subtests measuring VIQ, PIQ, and FSIQ (which is 
not an average value of VIQ and PIQ but a distinct mea-
surement of overall cognitive performance). WPPSI‐R 
and WISC‐R are designed for preschool and school‐aged 
children but are used also for adults with IDs for whom 
WAIS‐R is too demanding. LIPS comprises tasks in which 
instructions are given through pantomime and require only 
nonverbal, motor responses. BSID‐II consists of both ver-
bal and nonverbal subtests designed for toddlers. LIPS and 
BSID‐II can be applied to severely and profoundly intel-
lectually disabled individuals in all age groups; however, 
with adults these tests only determine developmental age, 
not IQ.
The neurologists (MA, AS, and NB‐L) examined clini-
cally the patients at the baseline and at the end of the study.
The relationship between IQ and chronological age was 
estimated by using random‐effects (generalized least squares) 
regression with quadratic term, subject identifier as a ran-
dom effect. The method accounts for the correlated structure 
of dependent variables arising from repeated measures over 
time, controlling for each individual.  Bootstrap estimation 
was used to derive a 95% confidence interval of curvilinear 
correlation.
The study was approved and reviewed by Pirkanmaa 
University Hospital District's ethics committee and written 
informed consent was received from each participant or their 
caregiver.
3 |  RESULTS
Of the 34 invited persons with WBS, 25 (18 women and 7 
men) agreed to participate. At baseline the study subjects’ 
ages ranged from 19 to 68 (median 38) and at end from 39 
to 86 (median 52). During the follow‐up seven women died 
and thus were assessed once only. Cardiovascular defects as-
sociated with diabetes mellitus type 2 was the cause of death 
in four women; their ages at death were 64, 68, 75, and 79. 
Two women had a fatal malignancy; a 27‐year‐old woman 
deceased to Hodgkin's disease and a woman aged 60 to my-
elodysplastic syndrome evolving to leukemia. A 32‐year‐old 
woman died of renal insufficiency.
Table 1 presents the state of health of the study subjects at 
the baseline and at the end of study. By the end of the study 
all study members had two to eight (median five) longstand-
ing health problems or impairments out of which hyperten-
sion, psychiatric disorder, and scoliosis or kyphosis occurred 
most commonly. Two women suffered from vascular demen-
tia confirmed by brain imaging.
Of the 25, 23 subjects were assessed using WAIS‐R or 
WISC‐R, one with LIPS, and one with WPPSI and BSID‐II. 
Figure 1 presents the course of FSIQ, VIQ, and PIQ in 23 
study subjects according to their chronological age. In our 
study group, mean FSIQ and mean PIQ improved between 
ages 19 to 50, after which age they gradually declined. 
Mean VIQ remained quite stable from age 19 to 40, after 
which age it gradually declined. At baseline, median FSIQ 
was 55, median VIQ 60, and median PIQ 56, while the re-
spective figures at end of follow‐up were 53, 52, and 64. 
Figure 2 presents FSIQs, VIQs, and PIQs of these 23 study 
subjects at the baseline and at the end of the follow‐up and 
the mean change of IQ scores. There was no difference be-
tween genders.
Two patients could not follow verbal instructions and thus 
were tested with other methods. The developmental age of 
the 32‐year‐old man, improved from 4.5 years to 5 years and 
the developmental age of the 34‐year‐old woman, declined 
from 2.8 years to 1.8 years. They both had three health is-
sues; the man had hypertension, hypercholesterolemia, and 
F I G U R E  1  Trajectories of full scale IQ, verbal IQ, and performance IQ on WAIS‐R/WISC‐R in 23 individuals with Williams syndrome
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diverticulitis and the woman had rectal prolapse, gastrointes-
tinal reflux, and hypertension.
4 |  DISCUSSION
Williams syndrome, like other ID syndromes, is a life‐long 
disorder. During the last decades the life expectancy of peo-
ple with IDs has increased and thus the number of senior 
citizens with IDs has grown (Arvio, Salokivi, & Bjelogrlic‐
Laakso, 2017; Arvio, Salokivi, Tiitinen, & Haataja, 2016). 
Therefore there is a need for research among elderly indi-
viduals with IDs (Coppus, 2013).
The strength of our study is a follow‐up lasting for 2 de-
cades; much longer follow‐ups are not feasible by the same 
authors. Another strength is the age range of our study group. 
To our knowledge, to date, the age of the oldest reported 
study subject with WBS is 52 years (Searcy et al., 2004), 
while 52 was the median age of the participants at the end of 
our study. The weakness of our research is the small size of 
the study group. On the other hand, WBS is a rare condition. 
Several earlier studies have shown that patients with WBS 
suffer from several somatic co‐morbidities (Coppus, 2013; 
Pober, 2010). This was also the case among our study sub-
jects and as expected seven out of 25 subjects died during the 
follow‐up. Cardiovascular disease associated with diabetes 
type 2 was the most common cause of death and malignant 
disorder the second most common; this is in line with earlier 
reports (Pober, 2010; Zhukova & Naqvi, 2013). In Finland, 
the most common causes of death at population are cardio-
vascular diseases and cancer in people aged over 60 years 
(Official Statistics of Finland, 2016).
Our study is the first longitudinal clinical follow‐up study 
describing the course of cognition in adulthood. In all but two 
subjects it was possible to apply the Weschler tests, which 
have been used in several nonFinnish studies (Boaddaert et 
al., ; Howlin et al., 1998, 2010; Martens et al., 2008; Searcy 
et al., 2004). The IQ results of this study representing early 
adulthood were in line with previous studies confirming that 
the mean VIQ of 20 to 30 year olds is slightly higher than PIQ. 
The novel finding of this study is that VIQ begins to deterio-
rate already after the age of 40, while PIQ and FSIQ continue 
to improve until the age of 50, after which age they also start 
to decline.
The relationship between the course of cognition and 
health can only be speculated because of the small study 
size and the limited health history that was available. For 
instance blood cholesterol levels were not routinely checked 
and coeliac disease, auditory defect, and sleep apnea were not 
diagnosed as precisely in 1990s as nowadays (Table 1). In ad-
dition, it is impossible to know howfor example, psychiatric 
co‐morbidities, joint luxations, or hypothyroidism may have 
influenced the cognition.
F I G U R E  2  Full scale IQ (a), verbal IQ (b), and performance 
IQ (c) of 23 individuals with Williams syndrome according to 
chronological age at the baseline, end of the study, and individual 
changes on WAIS‐R/WISC‐R scores. Box-and-whisker plot shows 95% 
confidence intervals of mean change
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In general population the cognitive functions start to de-
cline between ages 60–80 (Salthouse, 2009, 2010a, 2012, 2016; 
Schaei & Willis, 2010). According to the longitudinal studies 
so called “crystallized” intellectual functions (i.e., well‐learned 
skills, word, and general knowledge and deductive reasoning) 
remain quite stable even to age of 70 whereas the “fluid” in-
tellectual functions (i.e., problem solving in novel situations, 
cognitive processing speed, executive functions, and inductive 
reasoning) gradually weaken after age of 60 years (Rönnlund & 
Nilsson, 2006; Salthouse, 2010b, 2012, 2016; Scheie & Willis, 
2010). Premature ageing was obvious in our study group con-
sisting of persons with WBS, among whom the mental decline 
especially in “crystallized” intellectual functions (as deter-
mined by VIQ) occurred already after the age of 50. Our next 
step is to provide more detailed analyses of neuropsychological 
functioning in persons with WBS to guide and inform organi-
zation of services.
5 |  CONCLUSION
The course of cognition in adults with WBS is different com-
pared to general population. In WBS maximal VIQ is reached 
by young adulthood age, but PIQ and FSIQ improve until mid-
dle age. However, cognitive decline is uneven across the cog-
nitive profile; VIQ declines earlier than PIQ and FSIQ. Life 
expectancy in WBS may be shortened due to frequent somatic 
co‐morbidities and premature mental aging.
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